{"id":11653,"date":"2018-06-16T13:57:21","date_gmt":"2018-06-16T13:57:21","guid":{"rendered":"https:\/\/ilts.org\/?post_type=news&p=11653"},"modified":"2020-02-13T10:27:45","modified_gmt":"2020-02-13T09:27:45","slug":"vanguard-reports","status":"publish","type":"news","link":"https:\/\/old.ilts.org\/news\/vanguard-reports\/","title":{"rendered":"Vanguard Reports"},"content":{"rendered":"

A new series on highlights of the Joint Congress of ILTS, ELITA & LICAGE, Lisbon 2018<\/a><\/h4>\n
Edited by Prashant Bhangui<\/h5>\n
\n

Mamatha Bhat<\/a>\u00a0– Translational Science, Outcomes, Viral Hepatitis<\/p>\n

Ryan Chadha<\/a> – Anesthesia \/ Critical Care, The Marginal Candidate<\/p>\n

Alan Contreras<\/a> – Rising Star Abstracts, PSC, Limits in Oncology<\/p>\n

Varia Kirschner<\/a> – Graft Injury Mechanisms & Prevention, The High Risk Candidate<\/p>\n

Eleonora de Martin<\/a> – Marginal Candidate, Viral Hepatitis, Immunosuppression<\/p>\n

Amelia Hessheimer<\/a>\u00a0– NAS in DCD, Biliary Injury & Graft Fibrosis<\/p>\n

Gokhan Kabacam<\/a>\u00a0– Donor & Recipient Selection, ALF, Late-breaking Abstracts<\/p>\n

Marit Kalisvaart<\/a>\u00a0– AKI, DCD & Outcomes, Late-breaking Abstracts<\/p>\n","protected":false},"excerpt":{"rendered":"

A new series on highlights of the Joint Congress of ILTS, ELITA & LICAGE, Lisbon 2018<\/p>\n","protected":false},"featured_media":13351,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/old.ilts.org\/api\/wp\/v2\/news\/11653"}],"collection":[{"href":"https:\/\/old.ilts.org\/api\/wp\/v2\/news"}],"about":[{"href":"https:\/\/old.ilts.org\/api\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/old.ilts.org\/api\/wp\/v2\/media\/13351"}],"wp:attachment":[{"href":"https:\/\/old.ilts.org\/api\/wp\/v2\/media?parent=11653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}